Effects of granulocyte-colony stimulating factor on cardiac remodeling after myocardial infarction

Yasuhiro Takagi1, Minoru Yoshiyama, Takashi Omura

  • 1Department of Internal Medicine and Cardiology, Osaka City University, Graduate School of Medicine, 1-4-3, Asahimachi, Abeno-ku, Osaka 545-8585, Japan. ytakagi@hotmail.co.jp

Osaka City Medical Journal
|April 19, 2006
PubMed

Insights

Granulocyte colony-stimulating factor (G-CSF) treatment improved cardiac function after myocardial infarction (MI) in mice. G-CSF may prevent adverse cardiac remodeling by increasing matrix metalloproteinase-2 (MMP-2) expression.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Molecular Biology

Background:

  • Granulocyte colony-stimulating factor (G-CSF) shows potential in treating myocardial infarction (MI).
  • The precise molecular mechanisms of G-CSF's therapeutic effects on post-MI cardiac repair remain unclear.

Purpose of the Study:

  • To investigate the impact of G-CSF on cardiac function and remodeling following MI.
  • To explore the role of matrix metalloproteinase-2 (MMP-2) in G-CSF mediated cardiac repair.

Main Methods:

  • Mice underwent MI induction and were divided into control and G-CSF treated groups.
  • Cardiac function was assessed using Doppler echocardiography.
  • Non-infarcted myocardial mRNA expression, including MMP-2, was analyzed via northern blot.

Main Results:

  • MI significantly impaired cardiac function, evidenced by decreased E/A ratios.
  • G-CSF treatment significantly improved cardiac function (lower E/A ratios) compared to untreated MI mice.
  • Matrix metalloproteinase-2 (MMP-2) mRNA expression was significantly upregulated in G-CSF treated MI mice.

Conclusions:

  • G-CSF administration mitigates adverse left ventricular (LV) remodeling and cardiac dysfunction post-MI.
  • Upregulation of MMP-2 in non-infarcted myocardium is a potential mechanism for G-CSF's cardioprotective effects.
Abstract